Metastatic Breast Cancer Treatment Complicated by a Supplement–Drug Interaction

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: ER-positive, PR-positive, HER2-negative

Metastatic Site: bones

She resumed ribociclib with letrozole after the supplement was discontinued and the treatment-related neutropenia improved enough to restart therapy.

PubMed CentralRead more →

Breast Cancer Patient Avoids a Potential Supplement Interaction During Paclitaxel Treatment

Patient Info: Anonymized, female, 50s

Biomarkers: ER-positive, PR-positive

She continued cancer treatment with trastuzumab after completing the documented paclitaxel portion of therapy.

PubMed CentralRead more →

Stage IV Breast Cancer: Sherri's Patient Story

Patient Info: Sherri, Female | Stage IV

Biomarkers: BRCA1-negative

Metastatic Site: Bone marrow

As of November 2023, Sherri had no evidence of disease on recent breast cancer scans but remained on targeted treatment every 3 weeks and had started oxaliplatin after surgery for a separate Stage III colon cancer.

The Patient StoryRead more →

Psychological coping after a breast cancer diagnosis with Professor Dame Lesley Fallowfield

Patient Info: Anonymized

As of November 2023, this educational episode focused on psychological coping after breast cancer diagnosis, including anxiety, fear of recurrence, counselling resources, family reactions, and support services.

Stage IV Inflammatory Breast Cancer: Corky's Patient Story

Patient Info: Corky, Female, 60s | Stage IV

Metastatic Site: Not reported

As of October 2023, Corky was living with Stage IV inflammatory breast cancer as a chronic condition, receiving ongoing treatment focused on prolonging life and preserving quality of life.

Cleveland ClinicRead more →

Metastatic breast cancer: three years in remission with T-DM1 (Kadcyla) treatment

Patient Info: Anonymized, Female | Stage IV

Biomarkers: HER2-positive; hormone receptor-positive

Metastatic Site: liver; spine / bone

T-DM1 produced a complete clinical and radiological response after 7 cycles, sustained for 41 months and 60 cycles while treatment continued.

PubMed CentralRead more →

Breast cancer lung metastasis treated with a minimally invasive freezing procedure

Patient Info: Anonymized, Female | Stage IV

Biomarkers: HER2-positive; ER-negative

Metastatic Site: lungs

Follow-up PET/CT at 3, 6, 9 and 12 months after cryoablation showed no progression or new lesions without systemic therapy.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Brenda's Survivor Story

Patient Info: Brenda, Female, 40s

Brenda completed mastectomy, chemotherapy, radiation and an oophorectomy. She remained on anastrozole and a CDK4/6 inhibitor when she shared her story.

Lobular Breast Cancer AllianceRead more →

Stage IV HER2-Positive Inflammatory Breast Cancer: Olivia's Survivor Story

Patient Info: Olivia Franz, Female, Under 40 | Stage IV

Biomarkers: HER2-positive

Metastatic Site: Bones; distant lymph nodes

As of October 2023, Olivia continued to show no evidence of disease on scans while receiving maintenance trastuzumab and pertuzumab every 3 weeks and zoledronic acid every 3 months for bone health.

MD AndersonRead more →

Exercise Trainer Helps Detect Brain Metastases in a Woman With Long-Standing Metastatic Breast Cancer

Patient Info: Anonymized, female, 70+ | Stage IV

Biomarkers: ER-positive, PR-negative, HER2-negative

Metastatic Site: liver, bones, lymph nodes, kidney, brain

She died 5 months after the brain metastases were diagnosed, roughly 7 years after her original 2014 breast-cancer diagnosis.

PubMed CentralRead more →

Early-stage breast cancer (DCIS) found unexpectedly within a benign breast lump

Patient Info: Anonymized, Female

At 6 months she was asymptomatic with no palpable breast or axillary masses and entered annual MRI surveillance.

PubMed CentralRead more →

New Triple-Negative Breast Cancer Develops During Olaparib Treatment for a Separate Lung Cancer

Patient Info: Anonymized, female, 60s

Biomarkers: Triple-negative; germline BRCA2 mutation; BRCA2 reversion mutation

A woman receiving olaparib for BRCA2-mutated metastatic lung cancer developed a separate 14 mm triple-negative breast cancer with a BRCA2 reversion mutation.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Leigh's Patient Story

Patient Info: Leigh, Female

Leigh died in June 2022 from complications of ovarian cancer. Her lobular breast cancer experience led her to co-found the Lobular Breast Cancer Alliance and build a lasting patient-advocacy legacy.

Lobular Breast Cancer AllianceRead more →

Stage IV Triple-Negative Breast Cancer: April's Patient Story

Patient Info: April Donaldson, Female, 40s | Stage IV

Biomarkers: Triple-negative breast cancer; BRCA1 positive

Metastatic Site: Lungs

As of September 2023, April was living with Stage IV metastatic triple-negative breast cancer in the lungs; scans were stable in February but showed growth again in July, and PARP inhibitor therapy was being planned.

The Patient StoryRead more →

Breast tumor with extensive tissue death (infarction)

Patient Info: Anonymized, Female

Biomarkers: Oestrogen receptor-positive; HER2 equivocal; confirmatory HER2 FISH was not performed

After 1.5 years of endocrine therapy, there was no clinical evidence of residual tumour.

PubMed CentralRead more →

Triple-Negative Breast Cancer: Susan's Patient Story

Patient Info: Susan, Female, 70+

Biomarkers: BRCA negative; earlier breast cancer described as triple-negative; later breast cancer estrogen-positive and progesterone-positive; HER2 not reported

As of August 2023, Susan was living after multiple breast cancer diagnoses, including a later estrogen-positive/progesterone-positive non-metastatic breast cancer treated with bilateral mastectomy and ongoing 5-year estrogen-blocker therapy.

The Patient StoryRead more →

Kelly's Stage 3 Breast Cancer Story: “I’m Still Here & THRIVING!"

Patient Info: Kelly Thomas, Female, Under 40 | Stage III

Biomarkers: Initial triple-negative breast cancer; after surgery

As of August 2023, Kelly was 5 years from her Stage IIIC triple-negative breast cancer diagnosis with no recurrence reported.

The Patient StoryRead more →

HER2-Positive Breast Cancer: Susan's Survivor Story

Patient Info: Susan, Female, 70+

Biomarkers: 2021 breast cancer described as estrogen-positive and progesterone-positive; HER2 not reported. First breast cancer biomarker status not reported.

As of August 2023, Susan was living in survivorship after a first breast cancer treated with lumpectomy, chemotherapy, and radiation and a later separate breast cancer treated with bilateral mastectomy.

The Patient StoryRead more →

Occult Metastatic Breast Cancer First Appears as a Sternal Mass

Patient Info: Anonymized, female, 60s | Stage IV

Biomarkers: ER-positive, PR-positive, HER2-negative; BRCA1/2 testing negative

Metastatic Site: sternum

More than 3 years after the sternal mass was first detected, imaging showed no active breast or chest-wall disease and the cancers were described as appearing in remission while she continued tamoxifen.

PubMed CentralRead more →

Stage IV Breast Cancer: Britney's Patient Story

Patient Info: Britney Beadle, Female, Under 40 | Stage IV

Metastatic Site: Bone; liver; brain; lungs

As of August 2023, Britney was living with Stage IV breast cancer on Enhertu every 21 days, with liver clear and bone/lung disease showing regression on the latest described scan.

The Patient StoryRead more →

Stage IV Breast Cancer: Brittney's Patient Story

Patient Info: Brittney Beadle, Female, Under 40 | Stage IV

Metastatic Site: Bones; liver; brain; lungs

As of August 2023, Brittney was living with Stage IV breast cancer on ENHERTU every 21 days, with brain clear for 4.5 years, liver clear, and bone and lung disease regressing.

The Patient StoryRead more →

Stage IV Breast Cancer: Fadia's Survivor Story

Patient Info: Fadia, Female, Under 40 | Stage IV

Metastatic Site: Bone | Spleen | Lung | Liver | Brain

As of the August 2023 article update, Fadia had recovered after an initial 3-year breast cancer treatment course and later successful brain tumor surgery following repeated cancer involvement in multiple organs.

HER2-Positive Acantholytic Squamous Breast Cancer Responds Completely to Preoperative Therapy

Patient Info: Anonymized, female

Biomarkers: HER2-positive; postoperative residual in-situ disease ER-positive and PR-positive

The invasive cancer achieved a pathologic complete response, and she had no recurrence or metastasis during 1.5 years of follow-up.

PubMed CentralRead more →

Stage I Triple-Negative Breast Cancer: Melissa's Survivor Story

Patient Info: Melissa Berry, Female, 40s | Stage I

Biomarkers: BRCA mutation reported; triple-negative breast cancer

As of July 2023, Melissa was a 10-year Stage I triple-negative breast cancer survivor with no recurrence reported.

The Patient StoryRead more →